Clinical Trials Logo

Implant Site Infection clinical trials

View clinical trials related to Implant Site Infection.

Filter by:
  • None
  • Page 1

NCT ID: NCT05675241 Enrolling by invitation - Peri-Implantitis Clinical Trials

Characterizing the Inflammation Around Dental Implants

Start date: September 1, 2022
Phase:
Study type: Observational

The use of titanium dental implants has become a common modern treatment to restore teeth. Although the success rate of dental implants is high, inflammation around the dental implant still occurs. The current study will investigate if the inflammation around the implant is due to bacterial infection, hypersensitivity or both. The goal of this cross-sectional study is to (1) Establish the levels of cytokines in peri-implant crevicular fluid associated with bacterial infection and hypersensitivity reaction; (2) Compare the levels of cytokines associated with hypersensitivity and bacterial infection between healthy implants and inflamed implants (peri-mucositis and peri-implantitis); (3) Determine whether the difference in the levels of cytokines, if they exist, reflects the clinical diagnosis of healthy implants and inflamed implants.

NCT ID: NCT04787224 Completed - Clinical trials for Implant Site Infection

Vestibular Socket Therapy (VST) in Infected and Non Infected Sockets

VST
Start date: January 15, 2019
Phase:
Study type: Observational

Vestibular socket therapy with immediate implant placement is compared in infected and non-infected sockets regarding implant survival, bone thickness and soft tissue height .

NCT ID: NCT04731025 Recruiting - Clinical trials for Implant Complication

Local Antibiotics for Breast Implants

BREAST-AB
Start date: January 27, 2021
Phase: Phase 3
Study type: Interventional

The BREAST-AB Trial is a multi-center, randomized, double blind, placebo-controlled trial investigating the efficacy of local application of gentamicin, vancomycin and cefazolin in decreasing all-cause implant explantation after breast reconstruction.

NCT ID: NCT03343288 Completed - Implant Infection Clinical Trials

Silver Doped Ceramic Coated Orthopedic Implants

Start date: March 15, 2017
Phase: N/A
Study type: Interventional

In this study, CE (European Conformity) marked, domestic manufactured standard orthopedic implants will be used after silver HA coating with electrospray method in 30 patients requiring hip joint prostheses, intramedullary nails or external fixator in 30 patients to antimicrobial effectiveness. These patients will be tasted for liver and kidney functions and blood and urine silver levels in addition to routine tests such as full blood, complete biochemistry, C-reactive protein, erythrocyte sedimentation rate required in the normal diagnosis and treatment processes,

NCT ID: NCT03164408 Completed - Clinical trials for Implant Complication

Orthopaedic Implant Removal

Start date: January 1, 2014
Phase: N/A
Study type: Observational

The necessity of orthopedic implant removal is under intense discussion and even if it is performed as an elective procedure, the risk of complications is present. Aim of the study is to identify parameters responsible for an increased risk of early post-operative complications after elective aseptic orthopedic implant removal.

NCT ID: NCT02996929 Not yet recruiting - Clinical trials for Implant Site Infection

Safety and Performance of LeadExx LC System in Lead Extraction

Start date: February 2017
Phase: N/A
Study type: Interventional

The study's main purpose is to evaluate the safety and performance of the LeadExx LC System and its ability to safely extract leads. The study will enroll 10 patients scheduled for CIED lead extraction. The decision upon lead extraction will be based upon the applicable Heart Rhythm Society guidelines or European Heart Rhythm Association (EHRA).